Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Boehringer Ingelheim
Julphar
Covington
Mallinckrodt
AstraZeneca
McKesson
Colorcon

Generated: May 28, 2018

DrugPatentWatch Database Preview

STATOBEX Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Statobex, and when can generic versions of Statobex launch?

Statobex is a drug marketed by Teva and is included in three NDAs.

The generic ingredient in STATOBEX is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
Summary for STATOBEX
US Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: 10
Formulation / Manufacturing:see details
DailyMed Link:STATOBEX at DailyMed
Drug patent expirations by year for STATOBEX

US Patents and Regulatory Information for STATOBEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva STATOBEX phendimetrazine tartrate CAPSULE;ORAL 085507-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva STATOBEX phendimetrazine tartrate TABLET;ORAL 086013-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva STATOBEX-G phendimetrazine tartrate TABLET;ORAL 085095-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Fish and Richardson
Citi
QuintilesIMS
Cantor Fitzgerald
Cerilliant
Julphar
Chubb
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.